HROW Live signals | Maximize Profits with Getagraph.com

SELL 158946 min ago

@ $11.34

Issued: 13 Feb 2024 @ 15:41

Return: 58.29%

Previous signal: Feb 12 - 15:34

Previous signal: Buy

Return: -3.57 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	939 657
Average Volume	537 519
Market Cap	635.10M
EPS	$0 ( 2024-05-13 )
Next earnings date	( $-0.250 ) 2024-08-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-19.73
ATR14	$0.0190 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-25	Opaleye Management Inc.	Buy	20 000	Common Stock, par value $0.001 per share
2024-04-24	Opaleye Management Inc.	Buy	8 285	Common Stock, par value $0.001 per share
2024-04-23	Opaleye Management Inc.	Buy	11 715	Common Stock, par value $0.001 per share
2024-04-19	Opaleye Management Inc.	Buy	29 400	Common Stock, par value $0.001 per share
2024-03-28	Opaleye Management Inc.	Buy	50 000	Common Stock, par value $0.001 per share

INSIDER POWER
12.98
Last 96 transactions
Buy: 4 652 789 \| Sell: 3 289 598

Volume Correlation

Long: 0.46 (neutral)

Short: 0.16 (neutral)

Signal:(61.637) Neutral

Harrow Health Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Harrow Health Inc Correlation - Currency/Commodity

0.20
( neutral )

0.16
( neutral )

0.00
( neutral )

0.16
( neutral )

-0.33
( neutral )

Harrow Health Inc Financials

Annual	2023
Revenue:	$130.19M
Gross Profit:	$90.55M (69.55 %)
EPS:	$-0.750

FY	2023
Revenue:	$130.19M
Gross Profit:	$90.55M (69.55 %)
EPS:	$-0.750

FY	2022
Revenue:	$88.60M
Gross Profit:	$63.21M (71.35 %)
EPS:	$-0.510

FY	2021
Revenue:	$72.48M
Gross Profit:	$54.26M (74.87 %)
EPS:	$-0.690

Financial Reports:

No articles found.

Harrow Health Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Harrow Health Inc

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.